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The purpose of this paper is to identify a range of ethical considerations* that 
arise during the design and implementation of national health surveys that 
incorporate physical and biochemical measures. These include, for example, 
the gaining of informed consent, the nature of survey sampling, and the 
storage of biochemical samples. 
 
These cross-sectional surveys are able to provide important information on 
the prevalence of various health conditions and distributions of physical, 
mental and biochemical characteristics of the population, as well as providing 
data on the relationship between risk factors and selected conditions, and 
social and environmental determinants of health. In Australia, a program of 
national health measurement surveys that will collect a range of measures 
(physical and biochemical characteristics) is proposed, the Australian Health 
Measurement Survey (AHMS) program.  
 
The ethical, legal and social issues that arise are numerous. A number of 
broad policy issues emerge that require discussion. In order to ensure that 
survey programs are conducted within an ethical framework, these issues 
must be identified and discussed with communities and others, and broad 
agreement reached about the most appropriate ways to proceed. 
 
 
(* This paper is not intended to be a comprehensive review of all the ethical 
issues that may arise in the context of the AHMS program, nor of the methods 
that might be used in their resolution. The purpose of the paper is to raise 
some issues as part of the development of the AHMS Program in the hope 
that those who have the ultimate responsibility for its design and 







National sample surveys, which include physical and biochemical 
measurement, can provide important information on the prevalence of 
various health conditions and distributions of physical, mental and 
biochemical characteristics of the population, as well as data on the 
relationship between risk factors and selected conditions, and social and 
environmental determinants of health. Survey programs of this nature are 
now being conducted in many countries around the world, and the 
information that is collected is an important resource to support policy 
development and health planning. A program of national population health 
surveys using self-reported information and a range of more objective 
measures (physical and biochemical characteristics) is proposed for Australia, 
the Australian Health Measurement Survey (AHMS) program.  
 
There are a large number of legal and ethical issues that emerge once a survey 
with biochemical and other physical measures is proposed.  These include, for 
example, the gaining of informed consent, the nature of survey sampling, and 
the storage of biochemical samples. These need careful attention and 
discussion, and some may require legal opinions to reduce the likelihood of 
future legal claims and liability. 
 
Community involvement in a survey of this kind is critical to its success, 
given the response rates that are needed to ensure that results are 
representative of the population(s) of interest.  Significant investment is 
required to encourage participation and support at every stage of the survey.  
Consumer confidentiality and privacy concerns require a concerted effort and 
a planned strategy to address issues of data collection and usage, storage, 
security and access by researchers and others for analyses.  Consumer 
anxieties are also likely to be heightened when biomedical sampling, 
particularly of blood, is raised in the public domain.  The use of languages 
other than English and of appropriate interpreters, literacy levels, and the 
ability to understand and to give one’s own consent must be considered 
carefully.  Cultural and religious considerations, particularly regarding the 
taking of samples or physical measurements, will also be important. The 
benefits of these surveys and aspects of their methodologies need to be 
asserted and discussed fully. 
 
It is apparent that the ethical, legal and social issues that arise from a survey 
program of this kind are numerous, and will be determined largely by the 
survey design and its implementation. In order to ensure that the program is 
conducted within an ethical framework, these issues must be identified, 
discussed and broad agreement reached with the community about the most 




2. AN OVERVIEW OF NATIONAL HEALTH 





Monitoring and forecasting the population's health and health determinants 
are prerequisites for knowledge-based health policy and the development of 
health care at national, regional and local levels. National health measurement 
surveys are characterised by the collection of subjective information through 
questionnaires, and the gathering of more objective information via 
measurement of height, weight and body mass; factors in saliva, blood 
and/or urine; lung function; mental health and cognitive state; or childhood 
development. These surveys are also referred to as ‘health examination 
surveys’ in some countries.  
  
From an examination of the use of surveys of this type that have been 
undertaken around the world, the following purposes have been identified:   
 the monitoring within a population of certain high priority health goals 
and targets relating to the prevention of various diseases or conditions at 
one point in time, and over time as surveys are repeated regularly; 
 the provision of baseline data related to particular health issues or policies; 
 the contribution to particular research questions about health and related 
conditions and their treatment or eradication; 
 the surveillance of infective agents or other factors that impact negatively 
on the population’s health or may do so in the future; and 
 the collection of information at a population level - to assist in the 
development of policy and planning of services or determining need, to 
assess the degree of success of health promotion or illness prevention 
strategies and to contribute to a greater understanding of health and 
illness.   
 
Survey programs of this nature have been conducted for many years in the 
USA, some European and Asian countries, the United Kingdom and, more 
recently, in New Zealand, and serve as the base to support health policy, 
health research and prevention strategies in those countries. 
 
2.2   Experience in countries other than Australia  
Numerous countries such as Korea, Latvia, Pakistan, Greenland and Canada 
have conducted single national health measurement surveys.  The majority 
focused on cardiovascular health and included measures of body dimensions, 
blood pressure and analyses of blood samples.   
A number of international, collaborative surveys across countries have been 
established.  Examples of these include CINDI (Country-wide Integrated 
Non-Communicable Disease Intervention) and MONICA (Multinational 
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Monitoring of Trends and Determination in Cardiovascular Disease). The 
current WHO initiative, Stepwise Approach to Surveillance (STEPS) of non-
communicable disease risk factors, also uses standardised questions and 
measurement protocols at three levels of monitoring, depending on available 
resources, across developing and more developed countries worldwide 
(Bonita et al. 2001). 
However, some countries have now established, or are developing, ongoing 
programs of population health surveys using physical and biochemical 
measures.  The key design features of these programs are summarised in 
Table 2.1.  Of these, the programs in the US and the UK are the most 
sophisticated, and survey results and analyses have been highly valued for 
use by policy-makers and researchers.  Each conducts their survey on an 
annual, rolling basis and includes a wide range of physical and biochemical 
measures.  Both of these programs survey children, offer interview and 
measurement in respondents’ homes (or in mobile clinics), have a 
longitudinal component for follow-up of participants, some linkage to 
administrative data and store collected samples for further research.   
A number of countries are now favouring the survey design used by the UK 
Health Survey for England (HSE), which has a core content component 
(measured at every survey), and special interest modules (measured less 
frequently or opportunistically).  The core content is designed to monitor 
general health, common risk factors and the socioeconomic determinants of 
health over time.  Special interest modules examine particular health-related 
questions on an occasional or rotating basis in order to examine certain issues 
in greater depth.  The Scottish, New Zealand, and the US NHANES survey 
have also adopted this model (see Table 2.1). 
The degree to which ethical matters have been addressed in the development 
of these programs is seldom detailed and is often not able to be verified. 
However, there are a variety of ethical clearances that are in place regarding 
some significant issues such as consent for measures to be taken and for the 
storage of samples, data linkage and access to samples by researchers (see 
Table 2.2).   
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exam, muscular strength testing, oral health, 
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Height, weight, body dimensions, bio-
impedance, blood pressure, tests of physical 
and mental functioning, vision and hearing, 
oral and dental health, ECG, spirometry, 
Blood, saliva, urine, and faecal analyses 
 
n.a. 9 
n.a.* = Details not available in English 
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Table 2.2: Overseas Population Health Measurement Surveys – Ethical Issues 
 










Written, informed consent from each participant (12 years or older) for both the 
in-home interview and the health examination, and permission from parent or 
guardian for child under 18 years – general consent for participation and for 
information to be released according to legal provisions relating to confidentiality 
and privacy. 
No specific consent for DNA testing of anonymised stored samples – currently 
under review by NHANES. 
No release of information to anyone other than the respondent, except as required by law 
(public health notified diseases and child physical abuse notification) 
UK  
Health Survey for 
England 
Ethical approval 
obtained from the 
North Thames 
Multi-centre             
Research Ethics 
Committee 
(MREC) and from 




Written, informed consent for: 
Blood pressure results to be sent to GP (adult and child under 16 years) 
Sample of blood to be taken (adult 18+ years) 
Sample of blood to be taken (child 11-17 years) 
Blood sample results to be sent to GP (adult 18+, child 11-17 years) 
Blood sample for storage and unspecified testing (not of viruses) (adult 18+, child 
11-17 years) 
Blood sample result to be sent to respondent. 
FINLAND 
Health 2000 
n.a. Each participant is asked to sign a document that allows the National Public 
Health Institute to use his or her data in medical research. Several biological 







Informed consent from adult guardians and children, as well as assent. Consent 
for possible storage of samples, and for samples to be destroyed at the end of the 
survey. Consent for sending abnormal results to GP. 
n.a.* = Details not available in English 
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2.3   Experience in Australia  
There have been several national population based studies conducted in 
Australia that have included the collection of physical and biochemical 
measurements.  The key features of these surveys are outlined in Table 2.3.  
Many smaller surveys, usually focused on particular geographic areas or 
special populations of interest, have also included physical and biochemical 
measurements but only ‘national’ population based surveys are described 
below.  The National Heart Foundation’s Risk Factor Prevalence Study 
surveys of capital cities have been repeated over time and provide a time 
series of data on cardiovascular health.  
With the development of several survey programs overseas that include 
physical and biochemical measurement, there has been an increasing interest 
in Australia for establishing a similar, coordinated national program.  The 
first Australian proposal began as a single biochemical risk factor survey to 
repeat, and build on, the information obtained from the 1989 National Heart 
Foundation survey.  The proposal has since developed to follow the model 
adopted by the UK and USA, that of a coordinated national program of 
periodic population health measurement surveys to cover a range of public 
health issues over time.  An outline of the proposed Australian Health 
Measurement Survey (AHMS) program is described in Section 2.3.1. 
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Table 2.3: National population health surveys using physical and 
biochemical measurement in Australia 









sectional surveys in 
all capital cities in 
1980, 1983 and 1989 




Related to cardiovascular 
health:  blood, blood 
pressure, fasting glucose 









Fitness Survey  
 
Cross-sectional 






aged 7 to 15 
years 
Related to cardiovascular 
health:  blood, blood 















Related to blood lead 






national survey in 
1995 (undertaken on 





Body measurements, and 
















Related to cardiovascular 
disease and diabetes:  
blood, oral glucose 
tolerance test, body 
measurements, 
bioimpedance, spot urine 
and ECG;  (foot screening, 
sensory tests and retinal 
photography in a sub-
sample) 
 
 2.3.1 Outline of the proposed Australian Health Measurement Survey 
program 
 
The proposed AHMS program has been developed as a program of cross-
sectional surveys that include a component of physical and biochemical 
measurement, and will examine a range of disease outcomes and risks.  The 
broad aim of the program is the collection of population health information at 
a national level – specifically designed to assist in the development of health 
policy and service planning, to assess the degree of success of health 
promotion or illness prevention strategies and to contribute to a greater 
understanding of health and illness in Australia. 
 
The AHMS program will be nationally representative of people of different 
age, sex, geographic area and socioeconomic circumstances.  It will combine 
questionnaire responses and physical and biochemical measures (such as 
measurement of height and weight; analyses of samples of blood, urine, and 
saliva; and tests of function).  The program of surveys allows for the inclusion 
of a wider range of content areas than a single ‘stand-alone’ survey.  The 
design contains a 'core' of measures, which is likely to be repeated at each 
survey, with one or more modules on subjects of special interest undertaken 
opportunistically, and utilises a similar model to that which has been 
implemented successfully in the UK and the USA.  
 
A number of national health policy areas have been identified as important 
for inclusion in the AHMS program, such as chronic disease comorbidities, 
onset of risk factors in childhood, overweight and obesity, mental health, lack 
of physical activity and nutrition, in addition to risk factors for cardiovascular 
disease and diabetes mellitus. The survey will provide national prevalence 
estimates for a range of chronic diseases and conditions across relevant age 
groups.  
 
Two frameworks, The National Health Performance Framework (devised by the 
National Health Performance Committee (NHPC 2001) and AHMAC 
endorsed) and Preventing Chronic Disease: A Strategic Framework, (devised by 
the National Public Health Partnership (NPHP) (2001) and AHMAC 
endorsed) provide a mechanism to ensure national data collection develops in 
a coordinated way to fill information gaps in Australia.  The AHMS program 
offers an important opportunity to collect information to fill some gaps 
highlighted by these frameworks.  
 
The AHMS program is recommended to commence in association with the 
Australian Bureau of Statistics’ (ABS) National Health Survey (NHS), which 
collects health information by personal interview.  The first survey of the 
AHMS program would be conducted in association with the NHS in 2004/5, 
preceded by a dress rehearsal in 2003/4.  The program is, in effect, in two 
parts.  The first of these comprises the subjective measures undertaken in the 
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NHS.  The second includes the physical and biochemical measurement 
undertaken in the AHMS.  It is proposed that the survey be repeated after six 
years, with the possibility of more frequent (e.g. three yearly) surveys once 
the initial results have been analysed and their contribution to policy 
development, program planning and research assessed.   
 
The proposed objectives of the AHMS program are: 
 to determine the prevalence of selected disease outcomes and risk 
factors/determinants in the Australian population and selected 
population groups, as a basis for policy and strategy development; 
 to monitor trends in the prevalence of identified disease outcomes and 
risk factors/determinants in the Australian population and selected 
sub-population groups; 
 to examine the relationships among selected diseases and risk 
factors/determinants; and, 
 to validate self-report of selected risk factors/determinants using 
biological measures, in order to assess the validity of time trends in 
health indices obtained using self-report. 
 
Information from the surveys will be used: 
 to generate reliable evidence over time to be used for population health 
planning and the evaluation of several major disease prevention and 
control activities, including the National Health Priority Area (NHPA) 
strategies; 
 to examine the relationships among selected diseases and risk 
factors/determinants to assist in focusing research efforts and policy 
developments; 
 to provide the infrastructure for “opportunistic” testing of issues of 
concern (for example, lead or other pollutants) that may arise in the 
future; and, 
 to validate the self-report measures that are collected in face-to-face 
health surveys and potentially provide weights for adjustment of those 
surveys. 
 
Future opportunities for consideration within the AHMS program exist for 
administrative data linkage to cancer and death registries, possible sample 
storage and for the inclusion of a longitudinal component to allow follow-up 
of some participants over time, all subject to participant consent. These issues 
have been considered for the initial AHMS, but require considerable 
community consultation and ethical debate, and have been excluded from the 
proposed first AHMS at this time. 
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3. ETHICAL CONSIDERATIONS 
 
The development of national health measurement surveys gives rise to a 
significant range of ethical, legal and social issues. In order to ensure that such 
programs are conducted within an ethical framework, these issues must be 
identified, discussed and broad agreement reached about the most 
appropriate ways to proceed. 
 
 
3.1   An ethical framework for research in Australia  
 
Ethical considerations are essential to good research, and ethical inadequacies 
in a research program are as significant as scientific inadequacies (NHMRC 
1999). In Australia, research involving human participation must be 
conducted in accordance with agreed ethical considerations as set out in the 
National Statement on Ethical Conduct in Research Involving Humans 
(NHMRC 1999). In addition, international codes and agreements are also 
pertinent, such as the World Medical Association’s Declaration of Helsinki 
(amended October 2000). Research involving human participation is also 
subject to a variety of legal requirements at Federal, State and Territory levels.  
All research must comply with any relevant Commonwealth and 
State/Territory legislation (NHMRC 2000). 
 
Ethical principles serve to identify good, desirable or acceptable conduct in all 
spheres of human activity. There are four basic ethical principles that have 
been identified as the basis of ethical conduct in research involving humans 
(Gillon 1994; Beauchamp & Childress 1994; NHMRC 1999).  
 
These principles are: 
• Integrity of researchers – a commitment to the principles as set out in 
the Joint NHMRC/AVCC Statement and Guidelines on Research 
Practice 1997; 
• Respect for autonomy – the obligation to respect the autonomy of 
others, in so far as this is compatible with equal respect for the 
autonomy of all potentially affected; 
• Beneficence and non-maleficence – the obligation to maximise possible 
benefits and minimise possible harms. Researchers exercise beneficence 
in assessing the risks of harm and benefits to participants, in respecting 
the rights and interests of participants and in reflecting on the cultural 
and social implications of the research; 
• Justice – the obligation to act fairly and to address the question of who 
ought to receive the benefits of research and bear its burdens.  
 
Above all, research must be so designed that respect for the dignity and well 
being of participants, takes precedence over the expected benefits to 
knowledge (NHMRC 2000). However, there are instances where research has 
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not been designed nor conducted in accordance with these goals.  As an 
example, there is a long history in Australia of Aboriginal and Torres Strait 
Islander (ATSI) communities’ very different experience with research 
conducted by the non-Indigenous community. These research experiences 
have been exploitative, highly intrusive and disempowering, and have not 
served the interests of Indigenous people (McAullay et al. 2002).   
 
These precedents are reflected in the drafting of the NHMRC Guidelines on 
Ethical Matters in Aboriginal and Torres Strait Islander Health Research 
(1991), and a number of other research ethics guidelines that have been 
developed by Indigenous research bodies and organisations in consultation 
with their communities. Any research must be inclusive of Indigenous 
community interests and researchers must honour culturally different values, 
needs, practices and perspectives (Atkinson et al. 1994).  Significant issues 
include the importance of consultation (aimed at producing relevant 
research), community involvement, cultural appropriateness, consent, data 
and information ownership and the appropriate dissemination of research 
findings (McAullay et al. 2002). Most importantly, research needs to be 
relevant to identified health needs of Aboriginal and Torres Strait Islander 
communities, aimed at producing new knowledge, and of potential benefit to 
Indigenous health. Aboriginal and Torres Strait Islander communities are 
“particularly concerned about the use of information about Indigenous 
persons – particularly, what information is collected, by whom, how is it 
used, who owns the data, who has access and under what circumstances” 
(ABS & AIHW 1997). 
 
The recent advances made in relation to articulating ethics issues and 
processes for conducting ATSI health research have been significant.  These 
have been largely steered by ATSI community representatives, and may serve 
as a good model for broader community consultations around ethical issues 
in health research.  The processes in place around ATSI research ethics might 
be adapted for broader community consultations, particularly, for the ‘special’ 
consultative needs of other marginalised groups such as those who have drug 
and alcohol use problems, homeless people, those with mental health 
problems, and culturally and linguistically diverse peoples. 
 
3.2   The nature of the AHMS program  
  
The process of conducting a national health survey using physical and 
biochemical measures leads to ethical issues arising at each step in the 
process. For example, the initial steps of priority/agenda setting determining 
the need for a survey, and the allocation of funds to support its development 
have ethical dimensions that ought to be considered. The design of the survey 
program and the selection of special groups for inclusion in the sampling 
frame require ethical review. The choice of content areas and their 
measurement have ethical implications, as do issues surrounding the 
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feedback to participants of results. Informed consent and its scope, 
confidentiality and privacy of information must be considered, as well as the 
possible storage of samples and their future use.   
 
Participants in the AHMS program and the Australian community as a whole 
ought to be assured that each of these areas has been examined in detail and 
ethical considerations addressed, through a consultative process that allows 
for greater community involvement in identifying the ethical challenges that 
it sees as most important. 
 
3.3   Survey processes requiring ethical consideration 
 
3.3.1  Subject recruitment  
 
Participants in a survey program can be recruited in ways that can have 
ethical implications. This is particularly true if subjects are coerced into 
participating or are given false expectations. It may be unlikely that such 
coercion or deception would be overt; rather, it may be subtle and more 
difficult to detect. For example, the use of any incentives to encourage 
participation ought not precede the gaining of informed consent, as this may 
impair the voluntary character of that consent (NHMRC Statement, S1.10). 
 
The recruitment of special groups will require additional consultative 
processes. This is particularly relevant for groups such as Indigenous peoples. 
The survey design may present Indigenous Australians with more difficult 
choices about participation.  Additional information and consultation 
processes will be needed to facilitate decisions about whether or not to 
participate.  Particular attention will also be required in the development of 
survey protocols if seeking the involvement of children through their parents, 
to ensure that coercion does not occur to any extent. 
 
3.3.2  Informed consent 
 
During the recruitment phase, survey subjects should be clearly informed of 
the intent and activities required for participation. They should also be 
advised of possible consequences of participating in the survey (for example, 
that they may receive information about aspects of their health if they agree to 
do so). Participation in the survey will be voluntary and subjects should be 
informed that they can cease their participation at any stage of the survey. 
Issues of the extent of the consent to be sought from participants will be 
largely determined by the nature of the survey, its content and the age groups 
who will be asked to participate.  Languages other than English and the use of 
interpreters, literacy levels, and the ability to understand and to give one’s 
own consent will need to be thought through carefully.  Cultural 
considerations will also be very important for many groups in the 
community. 
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The ethical and legal requirements of consent have two components: the 
provision of information and the capacity to make a voluntary choice. The 
requirements for obtaining consent are outlined in the NHMRC Statement 
1999 (refer to S1.7). The onus is on researchers to ensure that each subject 
understands the implications of participating in the survey, is competent to 
consent and is exercising a voluntary choice. Informed consent is essentially a 
process. 
 
In some circumstances and in some communities, consent is not only a matter 
of individual agreement, but also involves other properly interested parties 
(for example, community elders in Indigenous communities). In such cases, 
researchers need to obtain the consent of all parties before commencing 
(NHMRC Statement, S1.9). In the case of research that involves Indigenous 
individuals or communities, the Interim NHMRC Guidelines on Ethical 
Matters in Aboriginal and Torres Strait Islander Health Research (NHMRC 
1991) should be consulted.   
 
When subjects are recruited, they should be informed of the benefits and risks 
of participation, details of the survey activities and any possible use of data of 
all kinds being collected. As part of the survey, some measures may involve 
the taking of samples of blood, saliva or other physiological substances. In the 
NHMRC Statement 1999, Section 15.4 outlines the requirement for consent 
where human tissue samples are collected for research purposes.  The 
collection of biochemical samples requires that the subjects be told, in lay 
language, of the purposes and risks of the sample taking, and the uses to 
which the samples will be put, as well as other information. Any information 
that is provided to participants must be provided in plain and accessible 
language.  In addition, the NHMRC Statement 1999 (S15.3) identifies the need 
for the institution responsible for the conduct of the survey to have policies in 
place that conform to relevant legislation and are consistent with the NHMRC 
Statement regarding tissue sampling. Such policies need to consider the 
source, nature and cultural or religious sensitivity of the sample, the original 
purpose for its collection, and the objectives of the research. Issues such as the 
access of other parties who may purport to have an interest in the information 
(for example insurance companies, police, family members) will require the 
development of protocols regarding data access and protection. 
 
A number of questions arise about the extent to which a researcher must go to 
inform participants of the unknown or unplanned use of samples, particularly 
if a decision were to be made to store and bank samples for future use in 
possibly unspecified research. What is the long-term responsibility of the 
researcher, or agency, to keep the participants informed of the use of their 
samples? What are the limitations of conducting additional analyses that are 
unrelated to the original survey purposes? To what extent does the initial 
informed consent cover any later research? Are the rights of participants 
disregarded when unspecified research is conducted on samples collected for 
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another purpose? Is there a duty to inform participants of the results of 
subsequent research? Is there a duty to inform participants of the subsequent 
disposal of the sample in the future?  These issues are significant and complex 
and the rights of participants must be ensured and safeguarded. 
 
One dilemma is whether a generic consent to undertake research on a sample 
given by a participant originally, is adequate consent to conduct a specific test 
on stored samples in the future. The obvious strategy of obtaining fresh 
consent has at least three major problems: (a) subjects may be very difficult to 
contact if follow-up has not been maintained or they are deceased, (b) a high 
proportion of non-consent either due to inability to re-contact or to refusal 
may bias the results, (c) for certain samples, multiple measures may emerge of 
interest and a process of very specific informed consent would generate an 
almost continuous stream of consent requests to the participant. Failure to 
obtain a new informed consent will expose a researcher to (a) allegations of 
unethical behaviour, and/or (b) a difficult situation if the measure 
information may be of clinical relevance to the participant, yet the participant 
was not counselled about the test before samples were taken and tested 
(Schulte et al. 1997).  
 
The banking and future use of samples also raises questions of the ownership 
of samples, and access to the samples and results by other researchers. 
Protocols to protect samples and to deal with possible requests for access from 
nonscientific interests, such as employers, police or insurance companies also 
needs to be addressed. For some communities, for example for Maori people, 
there may be a cultural requirement not to store samples, and to return any 
unused portion of a sample to its owner. 
 
In Australia, issues relating to sample storage, access and future use are dealt 
with in the NHMRC Statement 1999, which addresses such practices in 
paragraphs 1.7 to 1.12 and 15.4 to 15.8.  The effect of these paragraphs is that 
later use of collected tissue for research without consent would not comply 
with the National Statement, unless an institutional ethics body reviewing the 
AHMS program waived the consent requirement pursuant to paragraph 15.8.  
This is a key issue that would need to be resolved, for example, by providing 
participants with adequate information about how the samples will be used. 
The issue of sample storage in the AHMS program has been discussed but 
will not be undertaken at this time. 
 
The issue of genetic testing has been the subject of NHMRC attention and 
relevant advice is contained in the NHMRC Guidelines for Genetic Registers 
and Associated Genetic Material (1999) and Ethical Aspects of Human Genetic 
Testing – an Information Paper (NHMRC 2000).  
 For consideration:  
What procedures will be needed to ensure that consent is informed, voluntary and 
that the participant is capable of giving consent? 
Who on the survey team will be responsible for the gaining of informed consent? 
How will the giving of consent be recorded? 
Will survey information and consent forms be available in languages other than 
English? 
What are the cultural and religious issues associated with the survey design that 
may influence consent? 
What processes are the most appropriate for Indigenous peoples? 
Will the use of interpreters be offered? 
What about literacy issues? 
What about subjects with communication difficulties or other disabilities?  
What procedures will be in place to gain consent on behalf of children? How will 
the assent of children be gained? How will researchers determine if a child is able to 
consent on their own behalf? 
Will there be any people who are excluded from participating? On what grounds  18
 
 
3.3.3  Confidentiality and Privacy  
 
Confidentiality refers to an obligation that arises from a relationship, often 
contractual, between two parties in which one has given information to the 
other. The recipient is under an obligation not to use that information for any 
purpose other than that for which it was given. Legally, confidentiality is 
protected by the right of the person who provided the information to compel 
the recipient of the information to comply with their obligation (NHMRC 
2000). 
 
Privacy refers to a person’s interest in exerting effective control over the 
collection of, access to, use of, or disclosure of any personal information that 
has been collected or could be collected by another person (NHMRC 2000). In 
Australia, privacy is legally protected within the jurisdiction of the 
Commonwealth and in some States and Territories, by statutory codes of 
conduct that must be followed by public authorities. The Information Privacy 
Principles, in Section 14 of the Privacy Act 1988 (Cth) set standards to ensure 
privacy of personal information. The NHMRC has produced guidelines that 
reflect the Principles as they relate to health research (Guidelines Under 
Section 95 of the Privacy Act 1988, March 2000). The AHMS program and its 
processes must comply with these guidelines to ensure an ethical duty to 
participants is observed. 
Exceptions to obligations of confidentiality and to the statutory codes 
concerning privacy include when: 
should those decisions be made? 
What are the ethical implications of sample storage for future research, and how 
might this affect consent procedures? 
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• the information provider consents to the release of the information; 
• the law authorises or compels release; and/or 
• the information is released in the public interest (NHMRC 2000). 
Protocols for the survey will require consideration of confidentiality and 
privacy issues for possible sharing of information within the research team, 
for access to any long-term storage of samples and other data (if proposed at a 
later time), and for any administrative data linkage (if proposed at a later 
time). There will also need to be protocols developed for access to data by 
other researchers, non-scientific interests and possible family members of 
participants. Issues of consent, confidentiality and privacy from subsequently 




3.3.4 Interpretation and communication of test and survey results 
 
Several questions are pertinent to the sharing of information from a survey, 
including when to inform, whom to inform, how to inform, and maintaining 
the confidentiality of the information. The traditional paradigm that 
epidemiological research is concerned with data about group risk rather than 
individual effects is less appropriate in a survey of this kind. Participants are 
contributing to the research through their individual results, many of which 
may have particular and identifiable meaning for their own health status, and 
may represent opportunities to access treatment or preventive interventions. 
 
When to inform? 
There are three levels of need for information sharing which are likely to 
emerge in the implementation of the survey.  
 
i) The most urgent level of need will be where an emergency arises during the 
interview or measurement phase of the survey and transportation of a 
participant to a health facility or other service is required. Information 
regarding the health status and testing results if available should be given to 
For consideration: 
What mechanisms need to be in place at each stage of the survey to ensure that 
measures to protect confidentiality and privacy of participants comply with 
NHMRC guidelines and legal provisions? 
How will these provisions affect the objectives of the survey? 
To what extent will identified data be maintained and its protection ensured?  
What processes should be followed for de-identification of data? 
How will the privacy and confidentiality of participants who subsequently die be 
managed, particularly in the case of consent for future access to data or samples for 
additional research, if this is approved? 
How will the confidentiality and privacy of participants be ensured during the 
collection of measures? 
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the participant (or ambulance officer, if more appropriate) to transmit to the 
appropriate personnel at the receiving facility.  
 
ii) For the majority of measures performed as part of the survey, standard 
interpretations of the findings exist. For these measures, there is general 
scientific agreement regarding threshold levels. Consequently, these findings 
should be shared with the participant, subject their agreement. When the 
health status of the participant is known to be at risk, the information should 
be shared as a matter of priority. 
 
The participant should be given information on possible next steps that might 
be pursued to obtain further evaluation of the findings and their implications. 
Subjects whose measures are in the normative range should also be informed 
of the results, but not as rapidly as those with abnormal findings. Protocols 
will be required to set out standard interpretations of measures, consistently 
worded information and agreed approaches to the transmission of results to 
participants, with suggestions of further sources of assessment, such as 
general practitioners. The issue of consent from participants for the receipt of 
results will also need to be considered (see later). 
 
iii) For some measures performed as part of the survey, there may be no clear 
interpretations of the findings or agreed-upon critical levels. In such cases, it 
will be difficult to interpret the findings for a participant. Such a measure 
might be included in the survey because of the need to determine its 
distribution in the general population, but there may be no clear guidelines as 
to reportable levels. It should be considered whether or not to report these 
findings to participants on a measure-by-measure basis. 
 
Who to inform? 
Another ethical issue is who should be informed and there are a number of 
aspects to consider. In a survey of this kind, there is a probable duty of care to 
inform participants of results. Therefore all participants should be given the 
opportunity to receive results from the survey (with their consent), unless this 
is specifically contraindicated, either by the expressed wish of the person not 
to receive results, or because there are known circumstances that indicate 
such information would be harmful to a person’s emotional well being. In 
general, subjects should be provided with their results and some immediately 
useful information in exchange for their participation. The survey might 
represent an opportunity to provide participants with information about 
strategies to address certain aspects of their health risk. 
 
Additional complications arise if measures include genetic or DNA testing, or 
survey samples are made available for this type of testing at a later date. Is 
there a responsibility for the survey team to inform participants or their 
family members of a possible risk identified by the testing? Should pre- and 
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post-test counselling be offered in these circumstances? How practical might 
that be several years after completion of the survey? 
 
The family of a participant is often an interested party, not only in the case of 
any DNA testing, but also when previously unrecognised risk factors are 
found. Clearly, the family would share the burden of caring for an ill family 
member. However, the greater duty of care is clearly owed to the participant, 
and it is probably sound ethical practice to inform only the subject and allow 
him or her to determine whether family members should be informed. An 
exception to this is when the subject is a child. 
 
Other aspects should be considered. If an environmental health measure 
indicated a high exposure in a participant, what duty would exist to notify an 
employer or a relevant environmental health authority or to alert the 
participant to possible methods of exposure? To what extent should the 
results of measures be made available to parents if a young person is 
unwilling for this to occur? What extent of effort should occur to ensure 
notification of an abnormal result to a participant’s medical practitioner with 
the consent of the participant? 
 
How to inform? 
It is important that a subject is not ‘diagnosed’ by participating in a general 
population health survey of this kind. Rather, a subject should be informed 
that a finding is abnormal and that medical advice and follow-up should be 
sought. There are several reasons why a ‘diagnosis’ should not be used. There 
may be additional circumstances of which the survey team is unaware that 
contributed to the finding. Additional tests may be required to determine the 
status of the person more accurately, and information should be imparted in 
such a way that clarifies it as a risk, not as a diagnosis.  
 
The receipt of information about one’s personal health and the presence of 
new or existing risk factors can be a source of immediate anxiety, 
psychological distress and depression (Shaw et al. 1999). The receipt of a 
positive result on testing for risk factors in the majority of studies is normally 
associated with psychological distress, anxiety and depression in the first four 
weeks following, but only in a minority of cases are such effects evident for 
longer than this. Results from studies using experimental designs show that 
presenting results to participants and providing post-test emotional support 
prevents or reduces some of the mood disturbance following positive results. 
The ability to provide counselling for participants in the survey may be 
limited, but survey team members who are responsible for feeding back 
results should be aware of these issues.  
 
There are wider issues involved in the communication of results of the 
survey, especially for particular population sub-groups or communities. 
Gathering and interpreting data are unlikely to be independent from social 
 and political contexts. Where there are current debates over health risks, 
communicating the results of such data cannot be separated from the use of 
the data (Nelkin et al. 1989). Dissemination of risk information can have 
implications for citizens’ and employees’ rights to privacy, confidentiality and 
nondiscrimination, and researchers should be aware of the social power of 




If a testing procedure reveals a result that indicates that the person’s sample is 
abnormal or indeterminate, what level of reliability and sensitivity does this 
represent?  Will any re-testing be offered? 
What does an abnormal result mean for the person’s physical and mental wellbeing,
and future health?   
Who will be responsible for talking to the person and explaining the results?   
To whom should the information be given – the subject or his/her general  22
 
3.3.5  Special considerations for the involvement of children 
 
The inclusion of children and young people in a survey program of this kind 
will advance knowledge about their health and wellbeing. However such 
research should only be conducted where: 
• the research is important to the wellbeing of children and young 
people, 
• their participation is indispensable to the research, 
• the study method is appropriate for children and young people, and 
• the circumstances in which the research is conducted provide for the 
physical, emotional and psychological safety of the child or young 
person (NHMRC Statement 1999, S4).  
 
The gaining of consent to the participation of children and young people also 
involves special consideration. Consent must be obtained from a child or 
young person whenever he or she has sufficient competence to make this 
decision, and either 
• the parent/guardian in all but exceptional circumstances, for a child; or 
• any organisation or person required by law. 
 
Refusal to participate on the part of a child or young person must be 
respected (NHMRC 1999), and such a refusal will override parental 
practitioner, or both?  What about people who do not have a general practitioner?  
What about the case of a young person under the age of 18 years, and what is the 
duty of care to a young person whose legal guardians refuse to disclose an 
abnormal result?  What about the psychological impact of transmitting a false 
positive result to a person and subsequently discovering that it has been made in 
error?   
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permission. Thus where children are not able to give their own consent, in 
addition to consent from a parent or legal guardian, the assent of a child must 
also be gained. Assent refers to a child’s affirmative agreement to participate 
in research. Mere failure to object should not be construed as assent. All 
information given to a child must be age and developmentally appropriate, 
and accessible (i.e. in a language that the child understands).  
 
There is research evidence that surveying children can present certain 
methodological challenges, but considerable work has been undertaken in the 
area of questionnaire development and pre-testing with children of varying 
ages, from four years and older (Borgers et al. 2000; Scott 2000).  The 
recommendations from these studies should be used when the interviewing 
of children is undertaken, and appropriate design of questionnaires adopted. 
 
The benefits and possible harms associated with the taking of measures, 
particularly physiological samples such as blood, and the communication of 
results should be considered carefully. The use of microtechniques for the 
collection and assaying of samples should be investigated, as well as 
strategies to minimise any adverse effects of sample collection (e.g. the use of 
anaesthetic creams). The decision to allow blood sampling for a purpose such 
as this, which is non-therapeutic, must be the child’s, and it is inappropriate 
to insist on the taking of blood or other samples, if a child indicates either 






4. COMMUNITY INVOLVEMENT  
 
There is a significant responsibility to involve community members in the 
identification of ethical issues and in finding satisfactory solutions to resolve 
them. A range of strategies can be employed to undertake this, from 
consultation with consumer organisations and community representatives, to 
the use of focus groups and cognitive testing, to pilot testing of the survey 
processes.  
 
Consumer involvement in a survey of this kind is critical in determining its 
success, in order to achieve the response rates that are needed to ensure that 
the results are representative of the population(s) of interest.  Significant 
investment will be required to encourage consumer participation and support 
at every stage of the survey.  Consumer confidentiality and privacy concerns 
will require a concerted effort and a planned strategy to ensure issues of data 
collection, disposal or storage, security and access to researchers for analyses 
are handled ethically.  Consumer anxieties are also likely to be heightened 
when biochemical sampling, particularly of blood, is raised in the public 
domain.  The benefits of the survey and aspects of the methodology will need 
to be asserted and discussed fully, and community confidence gained if the 




4.1 Identified processes for the resolution of ethical issues 
 
There are a number of community consultation processes about ethical issues 
that are being or have been undertaken in Australia and overseas, which will 
assist in identifying different models of consultation with communities. Most 
have been implemented because of the rising community interest in genetic 
information and related research. These include the current Australian Law 
Reform Commission (ALRC) and Australian Health Ethics Committee’s 
(AHEC) Joint Inquiry into the Protection of Human Genetic Information; the 
US National Institute of General Medical Sciences (NIGMS) of the National 
Institutes of Health’s (NIH) Report of the First Community Consultation on 
the Responsible Collection and Use of Samples for Genetic Research; and the 
various consultations being undertaken by the Wellcome Trust and the UK 
Medical Research Council prior to the establishment of  BioBank UK (Ethical 
aspects and public consultation on Public Perceptions of the Collection of 
Human Biological Samples, March 2002). It is likely that a range of concerns 
will also emerge from consultations with communities in Australia regarding 
the AHMS program. 
 
There are a number of ways to proceed. Clearly each of the issues identified 
above requires careful thought and discussion. Existing Australian ethical 
guidelines will provide direction in some areas (NHMRC 1991). Advice can 
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also be sought from researchers and agencies in Australia and overseas who 
have experience in the conduct of surveys of this kind. The determination of 
the most appropriate solutions will be part of the more detailed planning of 
the survey, which will be required if agreement in principle is gained from 
AHMAC. 
A continuing process of consultation with consumer organisations, ethnic and 
Indigenous groups, and community representatives will be required to 
explore community attitudes and social, cultural, ethical and spiritual 
concerns about issues, and to determine the way(s) to proceed with the 
survey program’s development and execution. Ultimately the final survey 
will need to be placed before an Institutional Ethics Committee (as outlined in 
the NHMRC Statement 1999) for consideration and final ethical approval. 
 
4.2 Aboriginal and Torres Strait Islander communities 
 
Consultation is a key component of Indigenous involvement in research. A 
research proposal must be formulated in partnership with Indigenous 
communities and their consultative organisations, and underpinned by the 
principle of self-determination. The act of developing a research proposal 
independently of the Indigenous community has the effect of disempowering 
the participants from the outset (Atkinson et al. 1994), leading to research that 
will have been structured through non-Indigenous cultural perspectives and 
practices. There also needs to be a commitment to ongoing consultation 
throughout the life of a research proposal, not solely at its outset. 
Consultation should also produce consent at both the community and the 
individual level if a proposal is to be supported. 
 
Equity in research implies that Indigenous community participation in the 
conduct of the research. What opportunities exist for community 
participation? Where are the opportunities to employ Aboriginal and Torres 
Strait Islander people throughout the research process? What possible barriers 
and difficulties may there be, and how might they be resolved? 
 
Issues of dissemination of research findings are also fundamental and include 
ownership and publication of findings, consent for the further use of 
biological samples, storage of such samples, and destruction of identifiable 
data (McAullay et al. 2002).  Agreements need to cover the ethical use of 
information of all types, including community feedback, publication of 
research findings (including academic publication) and release of findings 
more widely via the media, for example.  
 
Indigenous participants in the survey program must be assured that each of 
these areas has been examined in detail and ethical considerations addressed. 
There is a responsibility to involve community members in the identification 
of ethical issues and in finding satisfactory solutions to resolve them. A range 
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of strategies can be employed to undertake this, from consultation with 
Indigenous organisations and community representatives, to the use of focus 
groups and cognitive testing, to pilot testing of the survey processes. 
Community involvement in a survey of this kind will be critical in 
determining its success, given the response rates that are needed to ensure 
that sampling is representative of the population(s) of interest.  Significant 
investment will be required to encourage participation and support at every 
stage of the survey.  Confidentiality and privacy concerns will require a 
concerted effort and a planned strategy to ensure issues of data collection, 
storage, security and access to researchers for analyses are handled ethically.  
Issues of blood sampling may also raise concerns, given the impact of the 
Human Genome Diversity Project on certain Indigenous communities 
(Dodson 2000).  A continuing process of consultation with Indigenous groups, 
and their community health representatives will be required to explore 
community views about the full range of ethical issues, and to determine the 
ways to proceed. Ultimately, any proposed survey should also be subject to 
the usual processes of ethical oversight by an appropriate Indigenous Ethics 





The development of a national health measurement survey program for 
Australia (the AHMS program) offers a significant opportunity to undertake 
consultations with a wide range of interested people and communities about 
the considerable ethical and social issues that will arise as a result of running 
a survey program of this kind.  There are many pertinent issues to consider 
and a number of different consultative approaches will be required, given the 
diversity of interests and communities. All aspects of the AHMS program will 
need to be discussed fully and community confidence gained, if the program 
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